As momentum on health care reform increases, the issue of comparative effectiveness research has been the subject of much attention. The Obama Administration made it a priority and budgeted $1.1 billion to compare drugs, medical devices, surgery and other ways of treating specific conditions. It also remains a serious concern to many as a potential means of rationing care. The outcome of this debate will have undeniable impact on pharmaceutical and life-science companies, patients, and physicians.
Jeffrey Sandman, CEO of Hyde Park Communications and Dr. Michael Miller, Senior Counselor to Hyde Park and President of HealthPolCom discuss comparative effectiveness research in this video podcast.
